Detection of Helicobacter pylori Seropositivity in Hyperemesis Gravidarum and Correlation with Symptoms

 

 Buy Article Permissions and Reprints

ABSTRACT

The aim of this study was to investigate whether there was a relationship between H. pylori (Helicobacter pylori) infection positivity and characteristics (time and duration) of hyperemesis gravidarum (HG) symptoms. Forty-seven pregnant women with HG and 39 pregnant controls at the same gestational weeks without any gastrointestinal symptoms were included in this prospective study. H. pylori serum Immunoglobulin (Ig) G concentrations were determined by enzyme-linked immunoadsorbent assay (ELISA) in patients with HG and controls. Positive serology for H. pylori was correlated with the duration of symptoms in patients with HG. The prevalence of H. pylori infection was 85.1% (40 of 47) and 64.1% (25 of 39) in patients with HG and controls, respectively (p <0.05, χ ² test). Mean values of H. pylori IgG (± standard deviation) were significantly higher in patients with HG than in controls (22.66 aIU/mL ± 22.34 vs. 11.54 aIU/mL ± 13.89, p <0.01, Student's t-test). In HG group, time (gestational weeks) and the duration (weeks) of HG symptoms for patients serologically positive and negative for H. pylori were 6.95 ± 1.55 versus 6.58 ± 1.78 weeks, (p >0.05, Student's t-test) and 8.35 ± 5.28 versus 11.40 ± 7.17 weeks (p >0.05, Mann-Whitney U-test), respectively. There was no correlation between duration of HG symptoms and serum H. pylori IgG concentrations. Although a majority of pregnant women with HG were serologically positive for H. pylori infection, there was no correlation between positive serology and duration of symptoms, which is not suggestive of a direct causal relationship between H. pylori infection and HG.

REFERENCES

• 1 Broussard C N, Richter J E. Nausea and vomiting of pregnancy.  Gastroenterol Clin North Am . 1998;  27 123-151
  CrossrefPubMedGoogle Scholar
• 2 Depue R H, Bernstein L, Ross R K, Judd H L, Henderson B E. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: aseroepidemiologic study.  Am J Obstet Gynecol . 1987;  156 1137-1141
  CrossrefPubMedGoogle Scholar
• 3 Leylek A, Çetin A, Toyaksi M. Hyperthyroidism in hyperemesis gravidarum.  Int J Gynecol Obstet . 1996;  55 34-37
  PubMedGoogle Scholar
• 4 Frigo P, Lang C, Reisenberger K, Kölbl H, Hirchl A M. Hyperemesis gravidarum associated with Helicobacter pylori seropositivity.  Obstet Gynecol . 1998;  91 615-617
  CrossrefPubMedGoogle Scholar
• 5 El Younis M C, Abulafia O, Sherer D M. Rapid marked response of severe hyperemesis gravidarum to oral erythromycin.  Am J Perinatol . 1998;  15 533-534
  PubMedGoogle Scholar
• 6 Jacoby E B, Porter K B. Helicobacter pylori infection and persistent hyperemesis gravidarum.  Am J Perinatol . 1999;  16 85-88
  PubMedGoogle Scholar
• 7 Koçak I, Akcan Y, Üstün C, Demirel C, Cengiz L, Yanik F F. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum.  Int J Gynecol Obstet . 1999;  66 251-254
  CrossrefPubMedGoogle Scholar
• 8 Hawtin P R. Serology and urea breath test in the diagnosis of H pylori infection.  Mol Biotechnol . 1999;  11 85-92
  PubMedGoogle Scholar
• 9 Oderda G, Vaira D, Holton J, Dowsett J F, Ansaldi N. Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood.  Gut . 1989;  30 912-916
  PubMedGoogle Scholar
• 10 von Wulffen H, Grote H J. Enzyme-linked immunosorbent assay for detection of immunoglobulin A and G antibodies to Campylobacter pylori.  Eur J Clin Microbiol Infect Dis . 1988;  7 559-565
  PubMedGoogle Scholar
• 11 Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.  Lancet . 1990;  335 1233-1235
  CrossrefPubMedGoogle Scholar
• 12 Sipponen P, Varis K, Fraki O, Korri U M, Seppala K, Siurala M. Cumulative 10 year risk of symptomatic duodenal and gastric ulcer in patients with or without gastritis.  Scand J Gastroenterol . 1990;  25 966-973
  PubMedGoogle Scholar
• 13 Hayakawa S, Nakajima N, Karasaki-Suzuki M, Yoshinaga H, Arakawa Y, Satoh K, Yamamoto T. Frequent presence of Helicobacter pylori genome in the saliva of patients with hyperemesis gravidarum.  Am J Perinatol . 2000;  17 243-247
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Sandıkçı M U, Doran F, Köksal F, Sandıkçı S, Uluhan R, Varınlı S, Akan E. Helicobacter pylori prevalence in a routine upper gastrointestinal endoscopy population.  Br J Clin Pract . 1993;  47 187-189
  PubMedGoogle Scholar
• 15 Al-Moagel M A, Evans D G, Abdulghani M E, Adam E, Evans D J, Malaty H M, Graham D Y. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saadui Arabia, and comparison of those with and without upper gastrointestinal symptoms.  Am J Gastroenterol . 1990;  85 944-948
  PubMedGoogle Scholar
• 16 Mégraud F, Brassens Rabbé P M, Denis F, Belbouri A, Hoa D Q. Seroepidemiology of campylobacter pylori infection in various populations.  J Clin Mirobiol . 1989;  27 1870-1873
  PubMedGoogle Scholar
• 17 Sack R B, Gyr K. Helicobacter pylori infection in developing world.  Lancet . 1993;  341 1274-1275
  PubMedGoogle Scholar
• 18 Blecker U, Lanciers S, Hauser B. Validation of a new serologic test for the detection of Helicobacter pylori.  Acta Gastroenterol Belg . 1993;  56 309-314
  PubMedGoogle Scholar
• 19 Glupczynski Y, Brutte A. Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment.  Am J Gastroenterol . 1990;  85 98-99
  PubMedGoogle Scholar
• 20 Hardy D J, Hanson C W, Hensey D M, Beyer J M, Fernandes P B. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.  J Antimicrob Chemother . 1988;  22 631-636
  PubMedGoogle Scholar
• 21 McNulty C A, Gearty J C, Crump B, Davis M, Donovan I A, Melilian V, Lister D M, Wise R. Campylobacter pyloridis and associates gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.  Br Med J . 1986;  293 645-649
  PubMedGoogle Scholar